Difference between revisions of "Team:Pasteur Paris/Week 1"
| Line 108: | Line 108: | ||
<div style="text-align: left"> | <div style="text-align: left"> | ||
<ol> | <ol> | ||
| − | <li style="text-align:left">Resuspension of DNA in 15µL of DNAse, RNAse free water: BBa_K808007, BBa_K808010, BBa_K808011, BBa_K808012, BBa_K808013, BBa_K808014, BBa_K936000, BBa_K316003.</li><br> | + | <li style="text-align:left">Resuspension of Biobrick (BB) DNA in 15µL of DNAse, RNAse free water: BBa_K808007, BBa_K808010, BBa_K808011, BBa_K808012, BBa_K808013, BBa_K808014, BBa_K936000, BBa_K316003.</li><br> |
<li style="text-align:left">Storage at -20°C.</li><br> | <li style="text-align:left">Storage at -20°C.</li><br> | ||
<li style="text-align:left">Transformation in DH5α Competent cells purchased from Invitrogen (# 18265-017) was done following the transformation protocol. (BBa_K808007, BBa_K808010, BBa_K808011, BBa_K808012, BBa_K808013, BBa_K808014, BBa_K936000, BBa_K316003).</li><br> | <li style="text-align:left">Transformation in DH5α Competent cells purchased from Invitrogen (# 18265-017) was done following the transformation protocol. (BBa_K808007, BBa_K808010, BBa_K808011, BBa_K808012, BBa_K808013, BBa_K808014, BBa_K936000, BBa_K316003).</li><br> | ||
| Line 148: | Line 148: | ||
<td width="100" valign="top"><p><strong>808012</strong></p></td> | <td width="100" valign="top"><p><strong>808012</strong></p></td> | ||
<td width="173" valign="top"><p>49.5</p></td> | <td width="173" valign="top"><p>49.5</p></td> | ||
| − | <td width="173" valign="top"><p> | + | <td width="173" valign="top"><p> N/A </p></td> |
<td width="173" valign="top"><p>56.5</p></td> | <td width="173" valign="top"><p>56.5</p></td> | ||
</tr> | </tr> | ||
Revision as of 19:26, 17 September 2015
Week 1Week 2Week 3Week 4Week 5Week 6Week 7Week 8Week 9Week 10Week 11Week 12Week 13Week 14Week 15 |
Week 1
^ |
|||||||||||||||||||||||||||||||||||||||